[PDF][PDF] Efficacy of Anti-Vascular Endothelial Growth Factor (VEGF) Therapy for Age-Related Macular Degeneration
S Bidiwala - Cureus, 2024 - cureus.com
Anti-vascular endothelial growth factor (VEGF) drugs are used for various diseases with
abnormal proliferation of blood vessels. The use of these drugs in wet age-related macular …
abnormal proliferation of blood vessels. The use of these drugs in wet age-related macular …
[HTML][HTML] Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
E Maggio, A Alfano, M Mete, G Pertile - Case Reports in Ophthalmology, 2022 - karger.com
The efficacy of intravitreal anti-VEGF may be reduced in vitrectomized eyes due to
accelerated drug clearance. Given its longer durability, brolucizumab may represent a …
accelerated drug clearance. Given its longer durability, brolucizumab may represent a …
THE EYE ГЛАЗ
ПА Перевозчиков, ДВ Перегудов… - THE EYE ГЛАЗ …, 2022 - elibrary.ru
Полипоидная хориоидальная васкулопатия (ПХВ)-это разновидность влажной формы
возрастной макулярной дегенерации (ВМД). Характеризуется образованием …
возрастной макулярной дегенерации (ВМД). Характеризуется образованием …
[PDF][PDF] Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
EMAAM Mete, G Pertile - 2022 - scienceopen.com
The efficacy of intravitreal anti-VEGF may be reduced in vitrectomized eyes due to
accelerated drug clearance. Given its longer durability, brolucizumab may represent a …
accelerated drug clearance. Given its longer durability, brolucizumab may represent a …